Shailee Samir Shah, MD

Clinical assistant professor of neurology at Feinberg School of Medicine.

Articles by Shailee Samir Shah, MD

Sharing Key Updates Proposed for Revised NMOSD Diagnostic Criteria: Shailee Samir Shah, MD

ByShailee Samir Shah, MD,Isabella Ciccone, MPH

January 12th 2026

The clinical assistant professor at Feinberg School of Medicine outlined some of the major revisions proposed for the NMOSD diagnostic criteria presented at ECTRIMS 2025. [WATCH TIME: 8 minutes]

Evolving Approaches to the Diagnosis and Management of Paraneoplastic Neurologic Syndromes: Ditte Primdahl, MD; Shailee Samir Shah, MD

ByDitte Primdahl, MD,Shailee Samir Shah, MD,Isabella Ciccone, MPH,Luke Halpern

May 9th 2025

A duo of experts from Feinberg School of Medicine discussed the growing role of clinical algorithms, risk stratification, and treatment considerations in managing paraneoplastic neurologic syndromes alongside cancer therapies. [WATCH TIME: 4 minutes]

Recognizing and Managing Paraneoplastic Neurological Syndromes: Ditte Primdahl, MD; Shailee Samir Shah, MD

ByDitte Primdahl, MD,Shailee Samir Shah, MD,Isabella Ciccone, MPH,Luke Halpern

April 16th 2025

A duo of neurology experts from Feinberg School of Medicine talked about the diagnostic challenges, evolving understanding, and clinical implications of paraneoplastic neurological syndromes. [WATCH TIME: 3 minutes]

Latest Updated Articles

Sharing Key Updates Proposed for Revised NMOSD Diagnostic Criteria: Shailee Samir Shah, MD
Published: January 12th 2026 | Updated:

Shailee Samir Shah, MD

Articles by Shailee Samir Shah, MD

Sharing Key Updates Proposed for Revised NMOSD Diagnostic Criteria: Shailee Samir Shah, MD

Evolving Approaches to the Diagnosis and Management of Paraneoplastic Neurologic Syndromes: Ditte Primdahl, MD; Shailee Samir Shah, MD

Recognizing and Managing Paraneoplastic Neurological Syndromes: Ditte Primdahl, MD; Shailee Samir Shah, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis

Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers

Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis

Using Human iPSC Models to Dissect PIRA Mechanisms in Progressive Multiple Sclerosis: Valentina Fossati, PhD

Phase 3b RESHAPE Study Evaluates Risk–Benefit of Switching From Ocrelizumab to BTK Inhibitor Remibrutinib